1. Home
  2. IMRN vs ILAG Comparison

IMRN vs ILAG Comparison

Compare IMRN & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • ILAG
  • Stock Information
  • Founded
  • IMRN 1994
  • ILAG 1981
  • Country
  • IMRN Australia
  • ILAG Hong Kong
  • Employees
  • IMRN N/A
  • ILAG 238
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • IMRN Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • IMRN 14.4M
  • ILAG 9.9M
  • IPO Year
  • IMRN N/A
  • ILAG 2022
  • Fundamental
  • Price
  • IMRN $1.58
  • ILAG $0.51
  • Analyst Decision
  • IMRN
  • ILAG
  • Analyst Count
  • IMRN 0
  • ILAG 0
  • Target Price
  • IMRN N/A
  • ILAG N/A
  • AVG Volume (30 Days)
  • IMRN 384.6K
  • ILAG 35.5K
  • Earning Date
  • IMRN 08-29-2025
  • ILAG 12-19-2025
  • Dividend Yield
  • IMRN N/A
  • ILAG N/A
  • EPS Growth
  • IMRN N/A
  • ILAG N/A
  • EPS
  • IMRN N/A
  • ILAG N/A
  • Revenue
  • IMRN $4,777,422.00
  • ILAG $7,506,551.00
  • Revenue This Year
  • IMRN N/A
  • ILAG N/A
  • Revenue Next Year
  • IMRN N/A
  • ILAG N/A
  • P/E Ratio
  • IMRN N/A
  • ILAG N/A
  • Revenue Growth
  • IMRN 48.63
  • ILAG 16.50
  • 52 Week Low
  • IMRN $1.42
  • ILAG $0.34
  • 52 Week High
  • IMRN $2.48
  • ILAG $1.06
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 33.02
  • ILAG 44.83
  • Support Level
  • IMRN $1.54
  • ILAG $0.45
  • Resistance Level
  • IMRN $1.62
  • ILAG $0.53
  • Average True Range (ATR)
  • IMRN 0.13
  • ILAG 0.07
  • MACD
  • IMRN -0.03
  • ILAG -0.00
  • Stochastic Oscillator
  • IMRN 18.84
  • ILAG 43.41

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

Share on Social Networks: